Hematobium schistosomiasis control for health management of labor force generation at Nkhotakota and Lilongwe in the Republic of Malawi—assumed to be related to occupational risk
In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be...
Saved in:
Published in | Tropical medicine and health Vol. 47; no. 1; pp. 28 - 12 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
BioMed Central
02.05.2019
BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective.
The egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3,
< 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0,
< 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and
value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction.
MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries. |
---|---|
AbstractList | Abstract Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective. Results The egg-positive prevalence was 34.3% (95% CI 28.5–40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2–17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6–10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1–6.9) to 0.9% (95% CI 0.3–3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction. Conclusions MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers’ health; the sound labor force generation is vital for economic growth and development in these areas and countries. Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective. Results The egg-positive prevalence was 34.3% (95% CI 28.5–40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2–17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6–10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1–6.9) to 0.9% (95% CI 0.3–3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction. Conclusions MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers’ health; the sound labor force generation is vital for economic growth and development in these areas and countries. In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective.BACKGROUNDIn Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective.The egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction.RESULTSThe egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3, p < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0, p < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and p value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction.MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries.CONCLUSIONSMDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries. In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In this study, we focused on the age groups, which are assumed to be major labor force generation. Hematobium schistosomiasis is supposed to be related to occupational activities in schistosome-endemic countries because of its infectious route. We chronologically followed the transition of schistosome egg-positive prevalence before and after mass drug administration of praziquantel (MDA) by using a urine filtering examination. We also analyzed the effectiveness of urine reagent strips from the cost perspective. The egg-positive prevalence was 34.3% (95% CI 28.5-40.5) just before MDA in June 2010 and the highest prevalence was in the age of twenties. The egg-positive prevalence reduced to 12.7% (95% CI 9.2-17.3, < 0.01) 8 weeks after the first MDA and the prevalence reduced to 6.9% (95% CI 4.6-10.0, < 0.01) after the second MDA in August 2011. The egg-positive prevalence after MDA in 2013 was reduced from 3.8% (95% CI 2.1-6.9) to 0.9% (95% CI 0.3-3.4) and value was 0.050. Using urine reagent strips after MDA, the positive predictive value decreased, but the negative predictive value remained high. The cost of one urine reagent strip and one tablet of praziquantel were US$0.06 and US$0.125 in 2013 in Malawi. If the egg-positive prevalence is 40%, screening subjects for MDA using urine reagent strips, the cost reduction can be estimated to be about 24%, showing an overall cost reduction. MDA of praziquantel can assuredly reduce schistosome egg-positive prevalence. The combination of MDA and urine reagent strips could be both a practical and cost-effective countermeasure for hematobium schistosomiasis. It is key to recognize that hematobium schistosomiasis could be considered a disease that is assumed to have some concern with occupational risk at Nkhotakota and Lilongwe in Malawi. From this point of view, it is very important to manage workers' health; the sound labor force generation is vital for economic growth and development in these areas and countries. |
ArticleNumber | 28 |
Author | Komai, Yoshihiro Nishiyama, Toshimasa Kuroda, Tomoaki Maeba, Hirofumi Miyake, Mari Mishima, Nobuyuki Darcy, Andrew W. Kanda, Seiji Shimono, Takaki Lamaningao, Pheophet Amano, Hiroyuki Ng’ambi, Susan Jemu, Samuel K. Tabuchi, Koichiro |
Author_xml | – sequence: 1 givenname: Nobuyuki orcidid: 0000-0002-4331-1824 surname: Mishima fullname: Mishima, Nobuyuki – sequence: 2 givenname: Samuel K. surname: Jemu fullname: Jemu, Samuel K. – sequence: 3 givenname: Tomoaki surname: Kuroda fullname: Kuroda, Tomoaki – sequence: 4 givenname: Koichiro surname: Tabuchi fullname: Tabuchi, Koichiro – sequence: 5 givenname: Andrew W. surname: Darcy fullname: Darcy, Andrew W. – sequence: 6 givenname: Takaki surname: Shimono fullname: Shimono, Takaki – sequence: 7 givenname: Pheophet surname: Lamaningao fullname: Lamaningao, Pheophet – sequence: 8 givenname: Mari surname: Miyake fullname: Miyake, Mari – sequence: 9 givenname: Seiji surname: Kanda fullname: Kanda, Seiji – sequence: 10 givenname: Susan surname: Ng’ambi fullname: Ng’ambi, Susan – sequence: 11 givenname: Yoshihiro surname: Komai fullname: Komai, Yoshihiro – sequence: 12 givenname: Hirofumi surname: Maeba fullname: Maeba, Hirofumi – sequence: 13 givenname: Hiroyuki surname: Amano fullname: Amano, Hiroyuki – sequence: 14 givenname: Toshimasa surname: Nishiyama fullname: Nishiyama, Toshimasa |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31073271$$D View this record in MEDLINE/PubMed |
BookMark | eNp9ks-OFCEQxjtmjftHH8CLIfHiZRSabpq-mJiNupuMmhg9k2q6epoZGkag3XjzIXwUn8gnkZlZN7t78EAKqK9-UPCdFkfOOyyKp4y-ZEyKV7HKoVxQ1uZR1wv5oDhhvGoXFauao1vz4-I0xjWlnNeSPiqOOaMNLxt2Uvy-wAmS78w8kahHE5OPfjIQTSTauxS8JYMPZESwaSQTOFjhhC4RPxALXU7ltEayQocBkvGOQCIfN6NPsMmDgOvJ0ljvVldIjCNpRPIZt3Nnjd5BPoCFK_Pn5y-IcZ6wJ8mTDklAC-mw8lrP2z0aLAkmbh4XDwewEZ9cx7Pi67u3X84vFstP7y_P3ywXWjCWFmWjRVvWkgmqdVf1mtbQc60Zqxsqami1wEpDJ4EKNvQSAUWrERjjHYiK87Pi8sDtPazVNpgJwg_lwaj9hg8rBSEZbVGxXsq6b5se9kwtS6p5mQ8u5SBEqTPr9YGVO89d6vyEAewd6N2MM6Na-e9KVK0Uos6AF9eA4L_NGJOaTNRoLTj0c1RlyVlLW0nbLH1-T7r2c8ivl1V1JSRvJWdZ9ez2jW6u8s8cWcAOAh18jAGHGwmjamdAdTCgygZUOwMqmWuaezXapP3f5aaM_U_lX8wE5ME |
CitedBy_id | crossref_primary_10_1186_s12913_022_07925_3 crossref_primary_10_1186_s41182_022_00450_3 crossref_primary_10_1186_s12920_023_01711_8 |
Cites_doi | 10.4269/ajtmh.1984.33.862 10.1016/0035-9203(89)90336-2 10.1186/1471-2334-11-169 10.1128/CMR.12.1.97 10.1186/s13071-014-0570-y 10.4314/mmj.v28i1.3 10.1016/j.pt.2003.10.002 10.1016/j.bjid.2014.11.004 10.1186/1756-3305-7-153 10.1016/S0022-5347(01)66763-6 10.1186/1471-2334-4-49 10.1186/1471-2334-4-40 10.1016/S2214-109X(17)30220-6 10.1542/peds.2014-3189 10.1016/S1473-3099(06)70521-7 10.1093/heapol/9.4.385 10.1016/S2214-109X(15)00047-9 10.1186/s13071-015-1165-y 10.1016/j.healthpol.2008.05.004 10.1371/journal.pntd.0002131 10.4269/ajtmh.2004.71.778 10.1016/S0140-6736(13)61949-2 10.1093/trstmh/trx037 10.1016/S0968-8080(06)27244-6 10.1016/S0035-9203(02)90229-4 10.1186/s40249-015-0053-1 10.1371/journal.pone.0143667 10.1007/s40647-016-0159-2 |
ContentType | Journal Article |
Copyright | 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. The Author(s) 2019 |
Copyright_xml | – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. – notice: The Author(s) 2019 |
DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8C1 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s41182-019-0155-8 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Public Health Database (ProQuest) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1349-4147 |
EndPage | 12 |
ExternalDocumentID | oai_doaj_org_article_1d885d97da6e4cac820c3260c28f662c PMC6498665 31073271 10_1186_s41182_019_0155_8 |
Genre | Journal Article |
GeographicLocations | Malawi Africa |
GeographicLocations_xml | – name: Africa – name: Malawi |
GrantInformation_xml | – fundername: ; grantid: JP23406025 |
GroupedDBID | --- .55 0R~ 123 29Q 2WC 53G 5VS 7X7 8C1 8FI 8FJ AAFWJ AAJSJ AASML AAYXX ABDBF ABUWG ACGFS ACUHS ADBBV ADRAZ ADUKV AFKRA AFPKN ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS ASPBG AVWKF BAPOH BAWUL BCNDV BENPR BFQNJ BMC C6C CCPQU CITATION CS3 DIK DU5 DYU E3Z EBD EBLON EBS ECGQY EJD ESX FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR ITC JSF JSH KQ8 M48 OK1 OVT OZF PGMZT PHGZM PHGZT PIMPY RNS ROL RPM RSV SOJ TR2 TUS UKHRP X7M 7.U ACRMQ AHSBF AL- C24 M~E NPM RJT RZJ TKC 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c611t-27c69258160ccb4dc05ad3cc1157065a9c6e4cab8a061fd8eae69cea113ba6433 |
IEDL.DBID | M48 |
ISSN | 1349-4147 1348-8945 |
IngestDate | Wed Aug 27 01:26:09 EDT 2025 Thu Aug 21 18:12:49 EDT 2025 Fri Jul 11 10:56:24 EDT 2025 Fri Jul 25 22:21:57 EDT 2025 Thu Jan 02 22:54:32 EST 2025 Thu Apr 24 23:08:37 EDT 2025 Tue Jul 01 02:53:15 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Hematobium schistosomiasis Labor health management Economic growth Malawi Occupational risk Urine reagent strips |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c611t-27c69258160ccb4dc05ad3cc1157065a9c6e4cab8a061fd8eae69cea113ba6433 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-4331-1824 |
OpenAccessLink | https://www.proquest.com/docview/2546839831?pq-origsite=%requestingapplication% |
PMID | 31073271 |
PQID | 2546839831 |
PQPubID | 5066164 |
PageCount | 12 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_1d885d97da6e4cac820c3260c28f662c pubmedcentral_primary_oai_pubmedcentral_nih_gov_6498665 proquest_miscellaneous_2231909809 proquest_journals_2546839831 pubmed_primary_31073271 crossref_primary_10_1186_s41182_019_0155_8 crossref_citationtrail_10_1186_s41182_019_0155_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-05-02 |
PublicationDateYYYYMMDD | 2019-05-02 |
PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Nagasaki – name: London |
PublicationTitle | Tropical medicine and health |
PublicationTitleAlternate | Trop Med Health |
PublicationYear | 2019 |
Publisher | BioMed Central BMC |
Publisher_xml | – name: BioMed Central – name: BMC |
References | C Bowie (155_CR22) 2004; 4 NC Lo (155_CR31) 2015; 3 H Guyatt (155_CR39) 1994; 9 MH Mostafa (155_CR3) 1999; 12 A Deribew (155_CR5) 2017; 55 CW Stecher (155_CR12) 2017; 111 AE Randall (155_CR26) 2002; 96 MG Chipeta (155_CR28) 2013; 7 DG Colley (155_CR4) 2014; 383 OJ Brady (155_CR37) 2017; 5 155_CR17 155_CR16 155_CR15 155_CR14 155_CR36 AA Fatiregun (155_CR40) 2009; 89 155_CR20 LA Tchuente (155_CR13) 2004; 71 P Makaula (155_CR33) 2014; 7 155_CR6 F Mutapi (155_CR25) 2015; 135 EC Faust (155_CR32) 1924; 3 155_CR8 VB Moyo (155_CR27) 2016; 28 155_CR9 AHN Mtethiwa (155_CR29) 2015; 4 L Savioli (155_CR38) 1989; 83 P Steinmann (155_CR11) 2006; 6 NM Koraitim (155_CR35) 1995; 154 155_CR2 Malawi Global Fund Coordinating Committee (155_CR19) 2002 AF Aenowo (155_CR7) 2015; 19 155_CR10 NR de Silva (155_CR1) 2003; 19 155_CR30 E Saathoff (155_CR23) 2004; 4 S Siziya (155_CR41) 1996; 42 S Dawaki (155_CR44) 2015; 10 LS Stephenson (155_CR42) 1984; 33 H Poole (155_CR21) 2014; 7 N Midzi (155_CR24) 2011; 11 SJ Krauth (155_CR43) 2015; 8 P Khurana (155_CR34) 1992; 95 D Palmer (155_CR18) 2006; 14 |
References_xml | – ident: 155_CR6 – volume: 33 start-page: 862 issue: 5 year: 1984 ident: 155_CR42 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.1984.33.862 – volume: 83 start-page: 805 issue: 6 year: 1989 ident: 155_CR38 publication-title: Trans R Soc Trop Med Hyg doi: 10.1016/0035-9203(89)90336-2 – ident: 155_CR8 – volume: 11 start-page: 169 year: 2011 ident: 155_CR24 publication-title: BMC Infect Dis doi: 10.1186/1471-2334-11-169 – ident: 155_CR10 – volume: 12 start-page: 97 issue: 1 year: 1999 ident: 155_CR3 publication-title: Clin Microbiol Rev doi: 10.1128/CMR.12.1.97 – volume: 7 start-page: 570 year: 2014 ident: 155_CR33 publication-title: Parasit Vectors doi: 10.1186/s13071-014-0570-y – volume: 28 start-page: 10 issue: 1 year: 2016 ident: 155_CR27 publication-title: Malawi Med J doi: 10.4314/mmj.v28i1.3 – volume: 19 start-page: 547 issue: 12 year: 2003 ident: 155_CR1 publication-title: Trends Parasitol doi: 10.1016/j.pt.2003.10.002 – volume: 19 start-page: 196 issue: 2 year: 2015 ident: 155_CR7 publication-title: Braz J Infect Dis doi: 10.1016/j.bjid.2014.11.004 – volume: 55 start-page: 3 issue: suppl 1 year: 2017 ident: 155_CR5 publication-title: Ethiop Med J – ident: 155_CR14 – volume: 7 start-page: 153 year: 2014 ident: 155_CR21 publication-title: Parasit Vectors doi: 10.1186/1756-3305-7-153 – volume: 3 start-page: 295 year: 1924 ident: 155_CR32 publication-title: Am J Hyg – volume: 154 start-page: 1714 year: 1995 ident: 155_CR35 publication-title: J Urol doi: 10.1016/S0022-5347(01)66763-6 – ident: 155_CR9 – volume: 4 start-page: 49 year: 2004 ident: 155_CR22 publication-title: BMC Infect Dis doi: 10.1186/1471-2334-4-49 – volume: 4 start-page: 40 year: 2004 ident: 155_CR23 publication-title: BMC Infect Dis doi: 10.1186/1471-2334-4-40 – volume: 95 start-page: 149 year: 1992 ident: 155_CR34 publication-title: J Trop Med Hyg – volume-title: An Integrated Response to HIV/AIDS and Malaria: Application to the Global Fund. National AIDS Commission year: 2002 ident: 155_CR19 – volume: 5 start-page: e680 year: 2017 ident: 155_CR37 publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(17)30220-6 – volume: 135 start-page: 536 issue: 3 year: 2015 ident: 155_CR25 publication-title: PEDIATRICS doi: 10.1542/peds.2014-3189 – ident: 155_CR30 – volume: 6 start-page: 411 year: 2006 ident: 155_CR11 publication-title: Lancet doi: 10.1016/S1473-3099(06)70521-7 – volume: 9 start-page: 385 issue: 4 year: 1994 ident: 155_CR39 publication-title: Health Policy Plan doi: 10.1093/heapol/9.4.385 – volume: 3 start-page: e629 year: 2015 ident: 155_CR31 publication-title: Lancet Glob Health doi: 10.1016/S2214-109X(15)00047-9 – volume: 8 start-page: 584 year: 2015 ident: 155_CR43 publication-title: Parasit Vectors doi: 10.1186/s13071-015-1165-y – volume: 89 start-page: 72 issue: 1 year: 2009 ident: 155_CR40 publication-title: Health Policy doi: 10.1016/j.healthpol.2008.05.004 – volume: 7 start-page: e2131 issue: 3 year: 2013 ident: 155_CR28 publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0002131 – volume: 71 start-page: 778 issue: 6 year: 2004 ident: 155_CR13 publication-title: Am J Trop Med Hyg doi: 10.4269/ajtmh.2004.71.778 – volume: 383 start-page: 2253 year: 2014 ident: 155_CR4 publication-title: Lancet doi: 10.1016/S0140-6736(13)61949-2 – volume: 111 start-page: 144 year: 2017 ident: 155_CR12 publication-title: Trans R Soc Trop Med Hyg doi: 10.1093/trstmh/trx037 – ident: 155_CR17 – volume: 14 start-page: 27 issue: 27 year: 2006 ident: 155_CR18 publication-title: Reprod Health Matters doi: 10.1016/S0968-8080(06)27244-6 – volume: 96 start-page: 29 year: 2002 ident: 155_CR26 publication-title: Trans R Soc Trop Med Hyg doi: 10.1016/S0035-9203(02)90229-4 – ident: 155_CR15 – ident: 155_CR20 – volume: 4 start-page: 25 year: 2015 ident: 155_CR29 publication-title: Infectious Dis Poverty doi: 10.1186/s40249-015-0053-1 – volume: 10 issue: 11 year: 2015 ident: 155_CR44 publication-title: PLoS One doi: 10.1371/journal.pone.0143667 – ident: 155_CR36 – ident: 155_CR2 – ident: 155_CR16 doi: 10.1007/s40647-016-0159-2 – volume: 42 start-page: 40 issue: 2 year: 1996 ident: 155_CR41 publication-title: Cent Afr J Med |
SSID | ssj0033580 |
Score | 2.1195993 |
Snippet | In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged children. In... Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in school-aged... Abstract Background In Malawi, hematobium schistosomiasis is highly endemic. According to previous studies, countermeasures have been conducted mainly in... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 28 |
SubjectTerms | Age groups Cooperation Economic growth GDP Gross Domestic Product Health education Hematobium schistosomiasis Infections Infectious diseases Labor force Labor health management Malawi Occupational risk Population Poverty Tropical diseases Urinalysis Urine Urine reagent strips |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELZQD4gL4p-FggaJE1LU_Nmxj4CoVojtAVGpt8h_20bdTSqSVa99iD4KT8STMGNno12E4MIhh8RO5Pgb2581428Ye5vaqkytl4lZGpWU0tpEOnKx25CmXFkf8pAtTsT8tPx8xs92Un1RTFiUB44dd5Q5KblTldPCl1ZbXLEsUo7U5nIpRG5p9sU1b7uZinNwQc690YeZSXHUl8SjcdtMsUGcJ3JvFQpi_X9imL8HSu6sPMcP2P2RMsL72NSH7I5vH7G7i9Ep_pj9mJPuameazRpwr0paAX23bnTf9DBGogNSU4hHHmE9BbxAt4RgBFRsPZwHCWpCCvQAJ5cX3aAv8QLdOvjSrLr2_NpD0wKSRvjqo0I2fWShV_q6-Xlzi0wc5zoHQwfGQzgnE--6HTFjoHD2J-z0-NO3j_NkTMaQWJFlQ5JXVqicywy73prS2ZRrV1hLYj2IqlY24GOkRoawdNJrLxBpnWWF0Uh7iqfsoO1a_5yBd0qZnHzEuS9F6aXTvNCaC2U4N4WbsXQLTm1HpXJKmLGqw45FijriWSOeNeFZyxl7N71yFWU6_lb5AyE-VSSF7fAA7a4e7a7-l93N2OHWXupx2Pc1JRdAximLbMbeTMU4YMkLo1vfbbAOMmqVKpmqGXsWzWtqCXLtqsgrfLvaM7y9pu6XtM1FEAUXpSLpwhf_499esnt5GCt0eP-QHQzfN_4Vcq_BvA7D7BebKTFI priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NbtQwELagSIgL4r9bCjISJ6So-bNjnxAgqhVie0BU2ltkj73bqLtxabLqtQ_Bo_BEPAkexxu6CPWwh6ydyNE3tr_JjL8h5G0KVZmCFYleaJmUAiARBkPsEMqUS7ChDtnshE9Pyy9zNo8f3LqYVrldE8NCbRzgN_Ij1G33m7kosvcXPxKsGoXR1VhC4y65h9JlmNJVzUeHq8AQX3C4SpEIWbIY1cwEP-pKZNbekcZsIcYSsbMvBfn-_3HOf1Mnb-xFx4_Iw0gi6YcB9cfkjm2fkPuzGCZ_Sn5NUYnV6Wazpt57RfWAzq0b1TUdjbnp1JNVOhyCpOsxBYa6BQ1mgc1g6TKIUiN2VPX05PzM9erc_6hqDf3arFy7vLK0aamnkfSbHTSz8SEztVJXze_rn56b-9XP0N5RbWk4OTNcuRvyxhQT3J-R0-PP3z9Nk1ieIQGeZX2SV8BlzkTGUwBdGkiZMgUAyvd4nJUEbktQWijPGRZGWGW5x15lWaGVJ0LFc7LXutbuE2qNlDrHqHFuS15aYRQrlGJcasZ0YSYk3YJTQ9QuxxIaqzr4MILXA561x7NGPGsxIe_GWy4G4Y7bOn9ExMeOqLkd_nCXyzpO4TozQjAjK6PCe4HnTuDJbwq5WHCew4Qcbu2ljgtBV_812wl5Mzb7KYxxGdVat_F9PMeWqRSpnJAXg3mNI_Hsuyryyt9d7RjezlB3W9rmLMiE81KimOHB7cN6SR7kYRbgQf1Dstdfbuwrz7N6_TpMpj9FFyqh priority: 102 providerName: ProQuest |
Title | Hematobium schistosomiasis control for health management of labor force generation at Nkhotakota and Lilongwe in the Republic of Malawi—assumed to be related to occupational risk |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31073271 https://www.proquest.com/docview/2546839831 https://www.proquest.com/docview/2231909809 https://pubmed.ncbi.nlm.nih.gov/PMC6498665 https://doaj.org/article/1d885d97da6e4cac820c3260c28f662c |
Volume | 47 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9swEBf9gNKXse9564IGexp484ckSw9jrKUljCWMskD3ZGRJSU0Te0scuv1b-wt3JzumGdkebLAlC8l3Z_3kO_2OkNeRyVhknAyLaaFCJo0JpUUXu_FpypVxPg_ZaCyGE_bpil_tkU16q-4FrnYu7TCf1GQ5f_vzx68PYPDvvcFL8W7FECXDohgjfzgP5T45hIkpQzsdsd6pkKLHz6-_mAylYrxzcu5s4pgcAfDJ0iSLt2YsT-y_C43-HVR5Z5a6uE_udfCSfmz14QHZc9VDcjTqHOiPyO8hcrTWRbleUBg88gqs6kWpV-WKdlHrFGAsbbdH0kUfHEPrKfUKg8XG0Zmnq0apUt3Q8c113egbOKiuLP1czutqdutoWVEAmPTStWza2MhIz_VtGQJmh6-ipU1NC0f9jpr2qr5De0wx8P0xmVycfz0bhl3ahtCIOG7CJDNCJVzGIjKmYNZEXNvUGKT1AflrZYRjRhdSA5aYWum0E6ATOo7TQgNASp-Qg6qu3DNCnVWqSNCbnDgmmJNW81RrLlTBeZHagEQb0eSm4zTH1Brz3K9tpMhbweYg2BwFm8uAvOkf-d4Sevyv8inKu6-IXNz-Rr2c5Z1p57GVkluVWe3HZQBTGQDFkUnkVIjEBORkoy35Rr9zTEMA2FSmcUBe9cVg2uiv0ZWr11AHsLeKlIxUQJ62ytX3ZKOcAcm21G6rq9slVXnt6cMFU0hy-Pyfbb4gx4m3BNy7f0IOmuXavQTo1RQDsp9dZXCWZ_GAHJ6ej79cDvxvDDx_mwy8wf0BxSYw1w |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxJtAgUWCC5JVP9e7B4R4VSlNckCtlNuy3t2kVhO71I4ibvwIfgcnfhG_hJn1gwah3nrwId61NdG8PbPfEPLC12nsa8u9bJYJL-Zae9xgiV27MeVCWzeHbDxhw6P40zSZbpGf3VkYbKvsbKIz1KbU-I18F3HbwZnzKHhz-tXDqVFYXe1GaDRicWC_rSFlq17vfwD-vgzDvY-H74deO1XA0ywIai9MNRNhwgPma53FRvuJMpHWiDoD5CmhmY21yrgCVzcz3CrLgGQVBFGmwH9H8N4r5Co4Xh81Kp32CV6EJUWX4MXc4yJO2ipqwNluFWMkD4k7diclicc3_KAbF_C_GPffVs1zvm_vFrnZBq30bSNlt8mWLe6Qa-O2LH-X_Boi8muZ5aslhWwZ0QqqcpmrKq9o2wtPITimzaFLuuxbbmg5o04McVlbOncg2CgrVNV0cnJc1uoELqoKQ0f5oizma0vzgkLYSj_bBqMbXzJWC7XOf3__AbkAWFtD65JmlrqTOs2v8hycMsWG-nvk6FIYd59sF2VhHxJqjRBZiFXq0MYsttyoJFIqYSJLkiwyA-J3zJG6xUrHkR0L6XImzmTDTwn8lMhPyQfkVf_IaQMUctHmd8jxfiNifLsb5dlctiZDBobzxIjUKPe_NMRqGoJtX4d8xlioB2SnkxfZGp5K_lWTAXneL4PJwDqQKmy5gj0Q0wtfcF8MyINGvHpKQKrTKEzh6XRD8DZI3Vwp8mMHS85igeCJjy4m6xm5Pjwcj-Rof3LwmNwInUYgSMAO2a7PVvYJxHh19tQpFiVfLluT_wB8Ymgm |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtNAEF6VIlVcEP8NFFgkuCBZ8d-udw8IASVKaRMhRKXczHp3k1pN7FI7irjxEDwKJx6HJ2Fm7ZgGod568CHetTXR_HtmvyHkua-T2NdWeNk0k14stPaEwRK7dmPKpbZuDtlozIfH8YcJm2yRX-uzMNhWubaJzlCbUuM38j7itoMzF1HQn7ZtER_3B6_Pvno4QQorretxGo2IHNpvK0jfqlcH-8DrF2E4eP_53dBrJwx4mgdB7YWJ5jJkIuC-1llstM-UibRGBBogVUnNbaxVJhS4vakRVlkO5KsgiDIFvjyC914j15OIBahjyaRL9iIsL7pkLxaekDFrK6qB4P0qxqgeknjsVGLMExs-0Y0O-F-8-2_b5gU_OLhFbrYBLH3TSNxtsmWLO2Rn1Jbo75KfQ0SBLbN8uaCQOSNyQVUuclXlFW374ikEyrQ5gEkXXfsNLafUiSQua0tnDhAb5Yaqmo5PT8pancJFVWHoUT4vi9nK0rygEMLST7bB68aXjNRcrfLf339AXgCW19C6pJml7tRO86u8AK1Msbn-Hjm-EsbdJ9tFWdhdQq2RMguxYh3amMdWGMUipRiXGWNZZHrEXzMn1S1uOo7vmKcufxI8bfiZAj9T5GcqeuRl98hZAxpy2ea3yPFuI-J9uxvl-SxtzUcaGCGYkYlR7n9piNs0BN6-DsWU81D3yN5aXtLWCFXpX5XpkWfdMpgPrAmpwpZL2APxvfSl8GWPPGjEq6MEIv8kChN4OtkQvA1SN1eK_MRBlPNYIpDiw8vJekp2QIfTo4Px4SNyI3QKgXgBe2S7Pl_axxDu1dkTp1eUfLlqRf4DFh5sXA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hematobium+schistosomiasis+control+for+health+management+of+labor+force+generation+at+Nkhotakota+and+Lilongwe+in+the+Republic+of+Malawi-assumed+to+be+related+to+occupational+risk&rft.jtitle=Tropical+medicine+and+health&rft.au=Mishima%2C+Nobuyuki&rft.au=Jemu%2C+Samuel+K&rft.au=Kuroda%2C+Tomoaki&rft.au=Tabuchi%2C+Koichiro&rft.date=2019-05-02&rft.issn=1348-8945&rft.volume=47&rft.spage=28&rft_id=info:doi/10.1186%2Fs41182-019-0155-8&rft_id=info%3Apmid%2F31073271&rft.externalDocID=31073271 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1349-4147&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1349-4147&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1349-4147&client=summon |